ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)

Manufacturer
Fenwal, Inc. | Fenwal International, Inc.
Effective date
2021-06-25
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
8
Source
full-release
Hydrated at
2026-05-31 20:37:15

Label at a glance#

ProductADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)
Active ingredientTrisodium Citrate Dihydrate, Dextrose Monohydrate, Anhydrous Citric Acid, Sodium Phosphate, Monobasic, Monohydrate, Sodium Chloride, Mannitol, Adenine
Label structure2 sections

Label contents#

Full prescribing information#

4R3428, 4R3429Fresenius Kabi Fenwal Blood-Pack Units Rx only Using Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) with an Integrally Attached Container of Adsol Red Cell Preservation Solution and Fenwal HighFlo Needle

SPL UNCLASSIFIED SECTION

Contains Y-Sampling Site for the collection of unanticoagulated whole blood samples for laboratory testing.

Instructions for Use

Collection Procedure:

Use aseptic technique.

  1. Note: Nominal tubing dimensions of product are 0.118" inner diameter x 0.025" wall thickness.

Note: If the Y-Sampling Site is not used, donor samples may be collected using an alternate method following standard procedures.

  1. Precautions:
  2. • Do not use unless the solutions are clear.
  3. • Before beginning procedure, obtain one access device for each Blood-Pack unit with Y-Sampling Site to be processed.
  4. 1. Identify Blood-Pack unit using appropriate donor identification system.
  5. 2. Adjust donor scale to desired collection weight and position primary container on the donor scale as far as possible below donor arm.
  6. 3. Clamp donor tubing between Fenwal HighFlo1 needle and primary container. This step may be performed prior to step 1 or 2.
  7. 4. Following blood center procedures, apply pressure to donor’s arm and disinfect site of venipuncture.
  8. 5. Remove needle cover per instructions below:
  9. Holding the hub and cover near the tamper-evident seal, twist cover and hub in opposite directions to break seal.
  10. Remove needle cover, being careful not to drag the cover across the needle point.

6. Following blood center procedures, perform venipuncture, appropriately secure donor needle and/or tubing and release clamp on donor tubing.

7. When good blood flow is established, stabilize the front of the needle guard to arm with tape. (see Figure 1)

8. Following blood center procedures, mix blood and anticoagulant in primary container at several intervals during collection and immediately after collection.

9. Collect the appropriate volume based on Blood-Pack unit used. Note: The volume of anticoagulant is sufficient for the blood collection indicated on Blood-Pack unit ± 10%.

10. Release the pressure on the donor’s arm as appropriate.

Precaution: Do not proceed with the remaining steps until the entire whole blood unit is collected.

11. To avoid possible contamination of the whole blood unit, before filling whole blood sample tubes, hermetically seal the donor tubing near the Y-Sampling Site on the side leading to the primary container using a metal clip or appropriate alternate method.

Precaution: Complete steps 12 - 20 within approximately 4 minutes after sealing the donor tubing to avoid possible clot formation in the tubing.

12. To collect samples, insert the access device by pushing firmly into the Y-Sampling Site until the membrane seal is penetrated (see Figure 2).

Note: If the access device is assembled such that the outer barrel is screwed onto the Luer, make sure to rotate clockwise upon insertion to avoid barrel detaching from Luer.

13. Open the cap on the access device (if applicable).

14. Directly align the vacuum sample tube with the internal needle in the access device. Insert vacuum sample tube into device until the stopper is punctured.

15. Allow vacuum sample tube to fill with blood then remove from the access device.

16. Repeat steps 14 and 15 until the desired number of vacuum sample tubes have been filled.

Notes:

  • If the access device needs to be replaced, clamp the tubing between the needle and the Y-Sampling Site. Then, grasp base of Sampling Site with one hand and pull the access device out with the other hand. Firmly insert the new access device. Remove clamp and continue sampling.
  • If the access device is assembled such that the outer barrel is screwed onto the Luer, make sure to rotate clockwise upon removal to avoid barrel detaching from Luer.
  • The access device can only be replaced one time.

Precaution: When replacing access device, be careful to avoid contact with any blood droplets on the Luer or sampling site. Discard used access device appropriately.

17. Release remaining pressure on donor’s arm.

18. If desired, apply clamp to donor tubing between needle and Y-Sampling Site.

19. Withdrawal of Needle (see Figure 3)

Precaution: The needle guard must be held stationary while the needle is withdrawn into it.

  1. a) Place folded sterile gauze over puncture site and hold in place with finger tip without exerting pressure.
  2. b) Hold sides of needle guard near the front, between the index finger and thumb. Pull the hub back smoothly until the needle is completely enclosed and securely locked into the needle guard.
  3. c) Confirm the needle is completely enclosed and securely locked into the needle guard.

20. Strip blood from donor tubing into primary container, mix and allow the tubing to refill; repeat once.

21. Seal at X marks on donor tubing to provide numbered aliquots of anticoagulated blood for typing or crossmatching.

Note: Step 22 may be performed prior to step 20 or 21 if desired.

22. Remove and discard the Y-Sampling Site and the donor needle in the needle guard into an appropriate biohazardous waste container following established procedures.

23. Component Preparation:

  1. • If a platelet concentrate is to be prepared, it should be separated from the Red Blood Cells within 8 hours after blood collection.
  2. • Fresh Frozen Plasma should be separated from the Red Blood Cells and placed in the freezer at -18°C or colder within 8 hours after blood collection.
  3. • Adsol Red Cell Preservation Solution should be added to the Red Blood Cells immediately after the removal of plasma. Preparation of AS-1 Red Blood Cells may vary depending on processing option selected:
  4. a) Within 8 hours of blood collection if whole blood is held at ambient temperature.
  5. b) Within 3 days of blood collection if whole blood is refrigerated.

24. At the appropriate time, prepare the Blood-Pack unit for centrifugation by thoroughly mixing the primary container end over end, then load the unit in a centrifuge cup per the instructions on page 3.

25. Following centrifugation, remove containers from the centrifugation cup taking care not to disturb the red blood cell / plasma interface.

26. Place primary container in plasma extractor and express plasma into empty Transfer Pack container by releasing pressure plate and opening closure in tubing of primary container.

27. When desired amount of plasma has been removed, clamp tubing between Y and plasma container.

28. Suspend Adsol Red Cell Preservation Solution Container, open closure in tubing and drain contents into primary container of CPD Red Blood Cells. Clamp tubing.

29. Hermetically seal and separate transfer tubing between the Y-connector and primary container. Be careful to avoid fluid splatter. Discard Adsol solution container.

30. Mix Adsol Red Cell Preservation Solution and red cells thoroughly.

31. Store suspended AS-1 Red Blood Cells between 1 and 6°C.

32. Infuse AS-1 Red Blood Cells within 42 days of collection.

4R3428figs
4R3428figs

Store at Controlled Room Temperature. Protect from freezing. Avoid excessive heat.

Definition of “Controlled Room Temperature”:

“A temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F); that results in a mean kinetic temperature calculated to be not more than 25°C; and that allows for excursions between 15°C and 30°C (59° and 86°F) that are experienced in pharmacies, hospitals, and warehouses. Provided the mean kinetic temperature remains in the allowed range, transient spikes up to 40°C are permitted as long as they do not exceed 24 hours ... The mean kinetic temperature is a calculated value that may be used as an isothermal storage temperature that simulates the non isothermal effects of storage temperature variations.”

Reference: United States Pharmacopeia, General Notices. United States Pharmacopeial

Convention, Inc. 12601 Twinbrook Parkway, Rockville, MD.

1 Van der Meer, P.F., & de Korte, D. “Increase of blood donation speed by optimizing the needle-to-tubing connection: an application of donation software.” Vox Sanguinis 2009, 97: 21-25

4R3428symb
4R3428symb

4R3428cup4R3428cupSorvall is a trademark of Thermo Fisher Scientific LLC.

© 2019 Fresenius Kabi AG. All rights reserved

4R3428mf
4R3428mf

47-23-13-535 REV: A

PACKAGE/LABEL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Code 4R3428 15 Units

Fresenius Kabi

Fenwal Blood-Pack Units Double

Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD); Satellite Container with Adsol Red Cell Preservation Solution

For the Collection and Processing of 450 mL Blood

Y-Sampling Site, 16 ga. Ultra Thin Wall Fenwal HighFlo Needle

Rx only

Each unit consists of a primary container with 63 mL of CPD solution containing 1.66 g Sodium Citrate (dihydrate) USP, 1.61 g Dextrose (monohydrate) USP, 188 mg Citric Acid (anhydrous) USP, 140 mg Monobasic Sodium Phosphate (monohydrate) USP, pH may have been adjusted with sodium hydroxide; one satellite container with 100 mL of Adsol Red Cell Preservation Solution containing 2.2 g Dextrose (monohydrate) USP, 900 mg Sodium Chloride USP, 750 mg Mannitol USP, 27 mg Adenine USP; one empty 400 mL Transfer-Pack container.

Sterile, non-pyrogenic fluid path.
See instructions for use.

Single use only/

Store at Controlled Room Temperature (refer to direction insert). Protect from freezing. Avoid excessive heat.

  • Open pouch by tearing across at notch.
  • Direct handling of product surfaces prior to extended storage in the foil pouch, may result in mold growth.
  • Unused units in open foil pouch may be kept up to 60 days by folding and securing open end of foil pouch to prevent possible loss of moisture, provided:
    • Units are not removed from foil pouch, or
    • Unused units removed from foil pouch are returned to the foil pouch within 12 hours. Units may be removed from the pouch and returned only once.
  • Units removed from the foil pouch (that are not returned to the pouch within 12 hours) must be used within 4 days (96 hours). Units out of the foil pouch for longer than 96 hours must be discarded.
  • Manufacturer
  • Fresenius Kabi AG
  • 61346 Bad Homburg / Germany

www.fresenius-kabi.com

Made in US

47-28-13-537 REV: A

4r3428pack
4r3428pack

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ANHYDROUS CITRIC ACID Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813
MANNITOL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
SODIUM CATION Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
95250459-30e4-45c1-b08a-993044f49109Product name220250805
efd58dcf-540a-4531-8766-e713129ca6f2Product name120250307
4b7700e3-6e0e-45e5-9d22-6f754d61386eProduct name220250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0942-6430-02ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)1 in 1 KITKIT18

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0942-6430ADSOL RED CELL PRESERVATION SOLUTION SYSTEM IN PLASTIC CONTAINER (PL 146 PLASTIC) (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTION) KIT [FENWAL, INC.]8Current NDC, Legacy NDC, 1 package rows20210626_d2ed3194-1ed8-4fb8-bc2a-1f1dc9e2cc4e.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
AdenineACTIVE INGREDIENTJAC85A21616
Anhydrous Citric AcidACTIVE INGREDIENTXF417D3PSL6
Dextrose MonohydrateACTIVE INGREDIENTLX22YL083G6
MannitolACTIVE INGREDIENT3OWL53L36A6
Sodium ChlorideACTIVE INGREDIENT451W47IQ8X6
Sodium Phosphate, Monobasic, MonohydrateACTIVE INGREDIENT593YOG76RN6
Trisodium Citrate DihydrateACTIVE INGREDIENTB22547B95K6
AdenineACTIVE MOIETYJAC85A21616
Anhydrous Citric AcidACTIVE MOIETYXF417D3PSL6
ANHYDROUS DEXTROSEACTIVE MOIETY5SL0G7R0OK6
MannitolACTIVE MOIETY3OWL53L36A6
PHOSPHATE IONACTIVE MOIETYNK08V8K8HR6
SODIUM CATIONACTIVE MOIETYLYR4M0NH376

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0942-64300942-6430-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ADSOL Red Cell Preservation Solution System in Plastic Container (PL 146 Plastic)ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION AND ADSOL PRESERVATION SOLUTIONFenwal, Inc.d2ed3194-1ed8-4fb8-bc2a-1f1dc9e2cc4e2021-06-25Exact identifier
ndc (package): 0942-6430-02
ndc (product): 0942-6430
ndc11 (package): 00942643002
spl id: 5be4ca7b-f2b9-4042-bd6f-83e2bb7aebe0
spl set id: d2ed3194-1ed8-4fb8-bc2a-1f1dc9e2cc4e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.